Ashlan J Kunz Coyne

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 36

Top Topics

Combination Therapy

Pseudomonas Aeruginosa

Acinetobacter Baumannii

Top Venues

Microbiology spectrum

Antimicrobial agents and chemotherapy

Open forum infectious diseases

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Mirna Eshaya, Callan Bleick, Samantha Vader, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens. Microbiology spectrum (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kaylee E Caniff, Callan Bleick, Michael Joseph Rybak
Sulbactam-durlobactam: A Novel β-lactam-β-lactamase Inhibitor Combination Targeting Carbapenem-Resistant Acinetobacter baumannii Infections. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Ashlan J Kunz Coyne, Shelbye Herbin, Kaylee E Caniff, Michael Joseph Rybak
Steno-sphere: Navigating the Enigmatic World of Emerging Multidrug-Resistant Stenotrophomonas maltophilia. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M Lagnf, Taylor Morrisette, Kyle C Molina, Alaina DeKerlegand, Melanie Rae Schrack, S Lena Kang-Birken, Athena L V Hobbs, Jazmin Agee, Nicholson B Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A King, Benjamin M Pullinger, Kimberly C Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P Veve, Bruce M Jones, Leonor M Rojas, Amy K Feehan, Marco R Scipione, Jing J Zhao, Paige Witucki, Michael Joseph Rybak
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022. Microbiology spectrum (2023)
Ashlan J Kunz Coyne, Carolina Orzol, Michael P Veve, Michael Joseph Rybak
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese. Open forum infectious diseases 10 (9) (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Amer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, Dana J Holger, Razieh Kebriaei, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Kyle Stamper, Amer El Ghali, Razieh Kebriaei, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Truc T Tran, César A Arias, Michael Joseph Rybak
Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model. Microbiology spectrum (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, Kyle C Stamper, Dana J Holger, Michael J Rybak, Ashlan J Kunz Coyne, Susan M Lehman, Michael Joseph Rybak
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology spectrum 10 (2) (2022)
Ashlan J Kunz Coyne, Amer El Ghali, Dana J Holger, Nicholas Rebold, Michael J Rybak
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious diseases and therapy 11 (2) (2022)
Katherine Lev, Ashlan J Kunz Coyne, Razieh Kebriaei, Michael J Rybak, Kyle Stamper, Dana J Holger, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium . Antibiotics (Basel, Switzerland) 11 (3) (2022)
Ashlan J Kunz Coyne, Mohammad H Alshaer, Anthony M Casapao, Veena Venugopalan, Carmen Isache, Jason A Ferreira, Christopher A Jankowski
Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection. Antimicrobial agents and chemotherapy 66 (10) (2022)
Ashlan J Kunz Coyne, Kyle Stamper, Razieh Kebriaei, Dana J Holger, Amer El Ghali, Taylor Morrisette, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Ashlan J Kunz Coyne, Anthony M Casapao, Carmen Isache, James Morales, Yvette S McCarter, Christopher A Jankowski
Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection. Microbiology spectrum 9 (2) (2021)